Discovery Laboratories, Inc. (NASDAQ:DSCO)
CAPS Rating:
A biotechnology company, which develops its proprietary surfactant technology as Surfactant Replacement Therapies for respiratory disorders and diseases.
A biotechnology company, which develops its proprietary surfactant technology as Surfactant Replacement Therapies for respiratory disorders and diseases.
Recs
upside now